Report Detail

Pharma & Healthcare Global Throat Cancer Therapeutics Market Size, Status and Forecast 2019-2025

  • RnM3674275
  • |
  • 16 August, 2019
  • |
  • Global
  • |
  • 96 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Laryngeal cancer are mostly squamous cell carcinomas, reflecting their origin from the skin of the larynx.Oropharyngeal cancer is a disease in which cancer form in the tissues of the throat (oropharynx).
There is an increase in the prevalence of throat cancer across the world despite advances in the research of therapeutics and the healthcare infrastructure. Throat cancer is one of the most prevalent cancer types in Europe, Asia, and North America. Additionally, the mortality rate of this indication has increased over the past few years in the US. This has resulted in a substantial unmet market that is attracting pharmaceutical vendors to introduce novel therapies to cater to the demand. Moreover, the increasing awareness programs by the vendors is expected to aid in the early diagnosis of throat cancer indications. These factors will fuel throat cancer therapeutics market growth during the forecast period.
In 2018, the global Throat Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Throat Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Throat Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Bristol-Myers Squibb Co.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Sanofi
...

Market segment by Type, the product can be split into
Surgery
Radiotherapy
Chemotherapy

Market segment by Application, split into
Oropharyngeal Cancer
Laryngeal Cancer

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Throat Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Throat Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Throat Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Throat Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Surgery
      • 1.4.3 Radiotherapy
      • 1.4.4 Chemotherapy
    • 1.5 Market by Application
      • 1.5.1 Global Throat Cancer Therapeutics Market Share by Application (2019-2025)
      • 1.5.2 Oropharyngeal Cancer
      • 1.5.3 Laryngeal Cancer
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Throat Cancer Therapeutics Market Size
    • 2.2 Throat Cancer Therapeutics Growth Trends by Regions
      • 2.2.1 Throat Cancer Therapeutics Market Size by Regions (2019-2025)
      • 2.2.2 Throat Cancer Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Throat Cancer Therapeutics Market Size by by Players
      • 3.1.1 Global Throat Cancer Therapeutics Revenue by by Players (2014-2019)
      • 3.1.2 Global Throat Cancer Therapeutics Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Throat Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Throat Cancer Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Throat Cancer Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Throat Cancer Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Throat Cancer Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Throat Cancer Therapeutics Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Throat Cancer Therapeutics Market Size (2014-2019)
    • 5.2 Throat Cancer Therapeutics Key Players in North America
    • 5.3 North America Throat Cancer Therapeutics Market Size by Type
    • 5.4 North America Throat Cancer Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Throat Cancer Therapeutics Market Size (2014-2019)
    • 6.2 Throat Cancer Therapeutics Key Players in Europe
    • 6.3 Europe Throat Cancer Therapeutics Market Size by Type
    • 6.4 Europe Throat Cancer Therapeutics Market Size by Application

    7 China

    • 7.1 China Throat Cancer Therapeutics Market Size (2014-2019)
    • 7.2 Throat Cancer Therapeutics Key Players in China
    • 7.3 China Throat Cancer Therapeutics Market Size by Type
    • 7.4 China Throat Cancer Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Throat Cancer Therapeutics Market Size (2014-2019)
    • 8.2 Throat Cancer Therapeutics Key Players in Japan
    • 8.3 Japan Throat Cancer Therapeutics Market Size by Type
    • 8.4 Japan Throat Cancer Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Throat Cancer Therapeutics Market Size (2014-2019)
    • 9.2 Throat Cancer Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Throat Cancer Therapeutics Market Size by Type
    • 9.4 Southeast Asia Throat Cancer Therapeutics Market Size by Application

    10 India

    • 10.1 India Throat Cancer Therapeutics Market Size (2014-2019)
    • 10.2 Throat Cancer Therapeutics Key Players in India
    • 10.3 India Throat Cancer Therapeutics Market Size by Type
    • 10.4 India Throat Cancer Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Throat Cancer Therapeutics Market Size (2014-2019)
    • 11.2 Throat Cancer Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Throat Cancer Therapeutics Market Size by Type
    • 11.4 Central & South America Throat Cancer Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Bristol-Myers Squibb Co.
      • 12.1.1 Bristol-Myers Squibb Co. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Throat Cancer Therapeutics Introduction
      • 12.1.4 Bristol-Myers Squibb Co. Revenue in Throat Cancer Therapeutics Business (2014-2019))
      • 12.1.5 Bristol-Myers Squibb Co. Recent Development
    • 12.2 Eli Lilly and Co.
      • 12.2.1 Eli Lilly and Co. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Throat Cancer Therapeutics Introduction
      • 12.2.4 Eli Lilly and Co. Revenue in Throat Cancer Therapeutics Business (2014-2019)
      • 12.2.5 Eli Lilly and Co. Recent Development
    • 12.3 F. Hoffmann-La Roche Ltd.
      • 12.3.1 F. Hoffmann-La Roche Ltd. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Throat Cancer Therapeutics Introduction
      • 12.3.4 F. Hoffmann-La Roche Ltd. Revenue in Throat Cancer Therapeutics Business (2014-2019)
      • 12.3.5 F. Hoffmann-La Roche Ltd. Recent Development
    • 12.4 Merck & Co., Inc.
      • 12.4.1 Merck & Co., Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Throat Cancer Therapeutics Introduction
      • 12.4.4 Merck & Co., Inc. Revenue in Throat Cancer Therapeutics Business (2014-2019)
      • 12.4.5 Merck & Co., Inc. Recent Development
    • 12.5 Sanofi
      • 12.5.1 Sanofi Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Throat Cancer Therapeutics Introduction
      • 12.5.4 Sanofi Revenue in Throat Cancer Therapeutics Business (2014-2019)
      • 12.5.5 Sanofi Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Throat Cancer Therapeutics. Industry analysis & Market Report on Throat Cancer Therapeutics is a syndicated market report, published as Global Throat Cancer Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Throat Cancer Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,116.10
      4,674.15
      6,232.20
      3,638.70
      5,458.05
      7,277.40
      606,645.00
      909,967.50
      1,213,290.00
      324,987.00
      487,480.50
      649,974.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report